Status:
RECRUITING
Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer
Lead Sponsor:
NYU Langone Health
Conditions:
Prostate Cancer
Eligibility:
MALE
40-85 years
Brief Summary
This will be a prospectively maintained research database. The purpose is to record baseline parameters and treatment outcomes following of Cryotherapy for ablation of clinically localized prostate ca...
Eligibility Criteria
Inclusion
- Evidence of focal prostate cancer confined to the prostate based on MRI imaging and prostate biopsy
- Patients with clinically localized prostate cancer (no evidence for or concern for metastatic spread of cancer outside of the prostate) will be counseled regarding treatment options. Those selecting focal Cryo prostate ablation will then be offered inclusion into this data collection.
Exclusion
- Men that are not diagnosed with prostate cancer.
- Men that are diagnosed with clinically localized prostate cancer, but select other treatment options as their desired treatment.
Key Trial Info
Start Date :
May 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2040
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT07184957
Start Date
May 1 2017
End Date
December 31 2040
Last Update
September 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016